Montecito Bank & Trust »

Vertex Pharmaceuticals Incorporated shares owned by Montecito Bank & Trust

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Montecito Bank & Trust from 13F filings

Historical chart of Montecito Bank & Trust investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Montecito Bank & Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Montecito Bank & Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $877k 2.2k 391.64
2025-03-31 $849k 1.8k 484.82
2024-12-31 $668k 1.7k 402.70
2024-09-30 $753k 1.6k 465.08

More positions owned by Montecito Bank & Trust

Nvidia Corp Equities (NVDA)
Ishares Russell 1000 Growth Etf Equities (IWF)
Microsoft Corp Equities (MSFT)
Ishares Core S&p 500 Etf Equities (IVV)
Vanguard Intermediate-term Bond Fixed Income (BIV)
Ishares Core U.s. Aggregate Bon Fixed Income (AGG)
Spdr S&p 500 Etf Trust Equities (SPY)
Vanguard Short-term Treasury Et Fixed Income (VGSH)
Alphabet Inc-cl A Equities (GOOGL)
Ishares Core S&p Mid-cap Etf Equities (IJH)
Ishares U.s. Treasury Bond Etf Fixed Income (GOVT)
Ishares Core Msci Eafe Etf Equities (IEFA)
Ishares Msci Usa Quality Factor Equities (QUAL)
Ishares Russell 1000 Value Etf Equities (IWD)
Jpmorgan Chase & Co Equities (JPM)

View all positions for Montecito Bank & Trust

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Jennison Associates
Morgan Stanley
FMR
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated